Alteration of the esophageal microbiota in Barrett's esophagus and esophageal adenocarcinoma

Abstract

The incidence of esophageal adenocarcinoma (EAC) has increased in recent decades, and its 5-year survival rate is less than 20%. As a well-established precursor, patients with Barrett's esophagus (BE) have a persistent risk of progression to EAC. Many researchers have already identified some factors that may contribute to the development of BE and EAC, and the identified risks include gastroesophageal reflux (GER), male sex, older age, central obesity, tobacco smoking, Helicobacter pylori ( H. pylori ) eradication, and the administration of proton pump inhibitors (PPIs) and antibiotics. The human gut harbors trillions of microorganisms, the majority of which are bacteria. These microorganisms benefit the human host in many ways, such as helping in digestion, assisting in the synthesis of certain vitamins, promoting the development of the gastrointestinal immune system, regulating metabolism and preventing invasion by specific pathogens. In contrast, microbial dysbiosis may play important roles in various diseases, such as inflammation and cancers. The composition of the microbiota located in the normal esophagus is relatively conserved without distinct microbial preferences in the upper, middle and lower esophagus. Six major phyla constitute the esophageal microbiota, including Firmicutes , Bacteroides , Actinobacteria , Proteobacteria , Fusobacteria and TM7 , similar to the oral microbiota. Streptococcus dominates the esophageal microbiota. However, the microbiota varies in different esophageal diseases compared to that in the healthy esophagus. The type I microbiota, which is primarily composed of gram-positive bacteria, is closely associated with the normal esophagus, while type II microbiota has enriched gram-negative bacteria and is mainly associated with the abnormal esophagus. These increased gram-negative anaerobes/microaerophiles include Veillonella , Prevotella , Haemophilus , Neisseria , Granulicatella and Fusobacterium , many of which are associated with BE. The microbial diversity in the esophagus is decreased in EAC patients, and Lactobacillus fermentum is enriched compared to that in controls and BE patients. Furthermore, the microbiota may be associated with BE and EAC by interacting with their risk factors, including central obesity, GER, H. pylori , administration of PPIs and antibiotics. Therefore, a large gap in research must be bridged to elucidate the associations among these factors. Some studies have already proposed several potential mechanisms by which the microbiota participates in human carcinogenesis by complicated interactions with the human host immune system and signaling pathways. The activa...

Human Gut Microbiota: Friend or Foe?

“…Results obtained from other studies revealed that Veillonella, Prevotella, Neisseria, and Fusobacterium are abundantly present in patients with BE. These bacteria were not detected in the esophagus of healthy subjects, and recently published studies by other authors confirmed these results [404,407].…”

Esophageal microbiome signature in patients with Barrett’s esophagus and esophageal adenocarcinoma

“…However, few information exist on upper GI, while the majority of studies have focused on sites easier and less invasive to sample. Moreover, the available studies have not been designed to comprehensively evaluate through 16S-based amplicon sequencing the whole normal-BE-EAC human mucosal spectrum and thus have yielded mixed results [24,39,40]. In the present study, we report not only…”

Gegen Qinlian decoction enhances immunity and protects intestinal barrier function in colorectal cancer patients via gut microbiota

“…Puerarin, the main component of GQD, can increase the abundance of Akkermansia to promote the expression of ZO-1 and occludin, thereby protecting the intestinal barrier function[ 52 ]. Activation of the LPS–TLR4–NF-κB pathway has been shown to be involved in inflammatory processes and malignant transformation[ 53 ]. SCFAs are present in metabolites of Bacteroides and Prevotella .…”